Anthropic is starting an internal drug discovery program as part of an effort to develop artificial intelligence tools designed for drugmakers, becoming the latest company to try and crack the healthcare market. At an event in San Francisco on Tuesday, Anthropic's life sciences head Eric Kauderer-Abrams said the company will focus on discovering treatments for "neglected" diseases that traditional biopharmaceutical companies wouldn't consider attractive targets. "We're doing this because we